Gut Microbiota Changes After Hormonal or Surgical Treatment for Endometriosis

article OA: closed CC0
AI-generated summary by claude@2026-06, 2026-06-10

This study analyzed gut microbiota in endometriosis patients before and after hormonal therapy or surgery, finding hormonal treatment increased Blautia and decreased Sutterella, while surgery increased inflammation-associated taxa.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PURPOSE: Although studies have suggested a link between gut microbiota and endometriosis pathophysiology, the effects of treatment for endometriosis remain unclear. METHODS: In this prospective observational study, 27 patients with stage III/IV endometriosis and 17 healthy controls provided a total of 56 fecal samples. In endometriosis patients, gut microbiota profiles were analyzed before and after hormonal therapy or surgery to assess treatment-related changes. 16S rRNA gene sequencing was used for microbiota analysis. RESULTS: No differences in α- or β-diversity were observed between the endometriosis and control groups, although patients with endometriosis had high levels of Acidaminococcus, Lachnoclostridium, and Paraprevotella and low levels of Odoribacter (all p < 0.05). Among the eight patients who received hormonal therapy, no significant changes in α- and β-diversity were observed between the pre- and post-treatment samples. A comparison of samples from the same individuals showed an increase in Blautia, which is associated with mental health stability, and a decrease in Sutterella, which is involved in regulating the intestinal barrier. In an exploratory analysis of patients without recurrence after surgery (n = 4), α-diversity significantly increased (p = 0.035), with stable β-diversity. Postsurgical increases were observed in 10 genera, including six inflammation-related taxa; five (Flavonifractor, [Eubacterium]_brachy_group, Hungatella, Incertae_Sedis, and Fournierella) are associated with anti-inflammatory effects. CONCLUSIONS: Hormonal therapy for endometriosis may help not only to control lesions but also to support mental health. Surgical treatment may alter the composition of inflammation-associated gut bacteria; however, these exploratory results from a small cohort should be interpreted with caution. Further studies with larger sample sizes are warranted.
Full text 18,372 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Methods

In this prospective observational study, 27 patients with stage III/IV endometriosis and 17 healthy controls provided a total of 56 fecal samples. In endometriosis patients, gut microbiota profiles were analyzed before and after hormonal therapy or surgery to assess treatment-related changes. 16S rRNA gene sequencing was used for microbiota analysis.

Results

No differences in α- or β-diversity were observed between the endometriosis and control groups, although patients with endometriosis had high levels of Acidaminococcus, Lachnoclostridium, and Paraprevotella and low levels of Odoribacter (all p < 0.05). Among the eight patients who received hormonal therapy, no significant changes in α- and β-diversity were observed between the pre- and post-treatment samples. A comparison of samples from the same individuals showed an increase in Blautia, which is associated with mental health stability, and a decrease in Sutterella, which is involved in regulating the intestinal barrier. In an exploratory analysis of patients without recurrence after surgery (n = 4), α-diversity significantly increased (p = 0.035), with stable β-diversity. Postsurgical increases were observed in 10 genera, including six inflammation-related taxa; five (Flavonifractor, [Eubacterium]_brachy_group, Hungatella, Incertae_Sedis, and Fournierella) are associated with anti-inflammatory effects.

Conclusions

Hormonal therapy for endometriosis may help not only to control lesions but also to support mental health. Surgical treatment may alter the composition of inflammation-associated gut bacteria; however, these exploratory results from a small cohort should be interpreted with caution. Further studies with larger sample sizes are warranted. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data underlying this article cannot be shared publicly for privacy reasons. The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. Supporting Information | Filename | Description | |---|---| | aji70211-sup-0001-FigureS1.tif179.2 KB | Supporting information file 1: aji70211-sup-0001-FigureS1.tif | Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

References

- 1C. Hogg, A. W. Horne, and E. Greaves, “Endometriosis-Associated Macrophages: Origin, Phenotype, and Function,” Frontiers in Endocrinology 11 (2020): 7. - 2H. S. Taylor, A. M. Kotlyar, and V. A. Flores, “Endometriosis Is a Chronic Systemic Disease: Clinical Challenges and Novel Innovations,” Lancet 397 (2021): 839–852. - 3R. S. Schenken and D. S. Guzick, “Revised Endometriosis Classification: 1996,” Fertility and Sterility 67 (1997): 815–816. - 4Y. Belkaid and T. W. Hand, “Role of the Microbiota in Immunity and Inflammation,” Cell 157 (2014): 121–141. - 5F. Sommer and F. Bäckhed, “The Gut Microbiota–Masters of Host Development and Physiology,” Nature Reviews Microbiology 11 (2013): 227–238. - 6J. C. Clemente, L. K. Ursell, L. W. Parfrey, and R. Knight, “The Impact of the Gut Microbiota on Human Health: An Integrative View,” Cell 148 (2012): 1258–1270. - 7B. Ata, S. Yildiz, E. Turkgeldi, et al., “The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women With Stage 3/4 Endometriosis and Healthy Controls,” Scientific Reports 9 (2019): 2204. - 8M. N. D'Alterio, C. Giuliani, F. Scicchitano, et al., “Possible Role of Microbiome in the Pathogenesis of Endometriosis,” Minerva Obstetrics and Gynecology 73 (2021): 193–214. - 9J. Shan, Z. Ni, W. Cheng, et al., “Gut Microbiota Imbalance and Its Correlations With Hormone and Inflammatory Factors in Patients With Stage 3/4 Endometriosis,” Archives of Gynecology and Obstetrics 304 (2021): 1363–1373. - 10I. Pérez-Prieto, E. Vargas, E. Salas-Espejo, et al., “Gut Microbiome in Endometriosis: A Cohort Study on 1000 Individuals,” BMC Medicine 22 (2024): 294. - 11H. Mori, F. Maruyama, H. Kato, et al., “Design and Experimental Application of a Novel Non-Degenerate Universal Primer Set That Amplifies Prokaryotic 16S rRNA Genes With a Low Possibility to Amplify Eukaryotic rRNA Genes,” DNA Research 21 (2014): 217–227. - 12J. Li, J. Xu, X. Guo, et al., “Odoribacter Splanchnicus—A Next-Generation Probiotic Candidate,” Microorganisms 13 (2025): 815. - 13Y. Furusawa, Y. Obata, S. Fukuda, et al., “Commensal Microbe-Derived Butyrate Induces the Differentiation of Colonic Regulatory T Cells,” Nature 504 (2013): 446–450. - 14A. Altomare, L. Putignani, F. Del Chierico, et al., “Gut Mucosal-Associated Microbiota Better Discloses Inflammatory Bowel Disease Differential Patterns Than Faecal Microbiota,” Digestive and Liver Disease 51 (2019): 648–656. - 15M. V. Vestergaard, K. H. Allin, C. Eriksen, et al., “Gut Microbiota Signatures in Inflammatory Bowel Disease,” United European Gastroenterology Journal 12 (2024): 22–33. - 16Z. Tamanai-Shacoori, I. Smida, L. Bousarghin, et al., “Roseburia spp.: A Marker of Health?” Future Microbiology 12 (2017): 157–170. - 17Y. S. Rosenthal, A. Rosenthal, H. Shalev Ram, S. Ram, G. Chodick, and G. Koren, “Association Between Oral Contraceptives and Serious Infections: A Population-Based Cohort Study,” British Journal of Clinical Pharmacology 87 (2021): 4241–4251. - 18R. Karim, F. Z. Stanczyk, H. N. Hodis, et al., “Associations Between Markers of Inflammation and Physiological and Pharmacological Levels of Circulating Sex Hormones in Postmenopausal Women,” Menopause 17 (2010): 785–790. - 19S. Nishijima, W. Suda, K. Oshima, et al., “The Gut Microbiome of Healthy Japanese and Its Microbial and Functional Uniqueness,” DNA Research 23 (2016): 125–133. - 20N. Ozato, S. Saito, T. Yamaguchi, et al., “Blautia Genus Associated With Visceral Fat Accumulation in Adults 20–76 Years of Age,” NPJ Biofilms and Microbiomes 5 (2019): 28. - 21M. A. Ghannoum, M. Ford, R. A. Bonomo, A. Gamal, and T. S. McCormick, “A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic,” Frontiers in Nutrition 8 (2021): 672390. - 22M. Matsunaga, M. Takeuchi, S. Watanabe, et al., “Intestinal Microbiome and Maternal Mental Health: Preventing Parental Stress and Enhancing Resilience in Mothers,” Communications Biology 7 (2024): 235. - 23S. H. Duncan, P. Louis, and H. J. Flint, “Cultivable Bacterial Diversity From the Human Colon,” Letters in Applied Microbiology 4 (2007): 343–350. 10.1111/j.1472-765X.2007.02129.xGoogle Scholar - 24A. Zim and A. Bommareddy, “Estrogen-Gut-Brain Axis: Examining the Role of Combined Oral Contraceptives on Mental Health through Their Impact on the Gut Microbiome,” Cureus 17 (2025): e81354. - 25J. Mihajlovic, M. Leutner, B. Hausmann, et al., “Combined Hormonal Contraceptives Are Associated With Minor Changes in Composition and Diversity in Gut Microbiota of Healthy Women,” Environmental Microbiology 23 (2021): 3037–3047. - 26O. Yoshino, N. Takahashi, and Y. Suzukamo, “Menstrual Symptoms, Health-Related Quality of Life, and Work Productivity in Japanese Women With Dysmenorrhea Receiving Different Treatments: Prospective Observational Study,” Advances in Therapy 39 (2022): 2562–2577. - 27K. Hiippala, V. Kainulainen, M. Kalliomäki, P. Arkkila, and R. Satokari, “Mucosal Prevalence and Interactions With the Epithelium Indicate Commensalism of Sutterella spp,” Frontiers in Microbiology 7 (2016): 1706. - 28F. Hearn-Yeates, A. W. Horne, S. O'Mahony, and P. T. K. Saunders, “The Impact of the Microbiota-Gut-Brain Axis on Endometriosis-Associated Symptoms: Mechanisms and Opportunities for Personalised Management Strategies,” Reproduction and Fertility 5 (2024): e230085. - 29N. O. Kaakoush, “Sutterella Species, IgA-Degrading Bacteria in Ulcerative Colitis,” Trends in Microbiology 28 (2020): 519–522. - 30S. Hu, Q. Ding, W. Zhang, M. Kang, J. Ma, and L. Zhao, “Gut Microbial Beta-Glucuronidase: A Vital Regulator in Female Estrogen Metabolism,” Gut Microbes 15 (2023): 2236749. - 31A. H. Larnder, A. R. Manges, and R. A. Murphy, “The Estrobolome: Estrogen-Metabolizing Pathways of the Gut Microbiome and Their Relation to Breast Cancer,” International Journal of Cancer 157, no. 4 (2025): 599–613, https://doi.org/10.1002/ijc.35427. - 32G. Nannini, F. Cei, and A. Amedei, “Unraveling the Contribution of Estrobolome Alterations to Endometriosis Pathogenesis,” Current Issues in Molecular Biology 47 (2025): 502. - 33K. Takada, V. G. Melnikov, R. Kobayashi, S. Komine-Aizawa, N. M. Tsuji, and S. Hayakawa, “Female Reproductive Tract-Organ Axes,” Frontiers in Immunology 14 (2023): 1110001. - 34Y. Ou, H. Wang, C. Zhou, et al., “Endometriosis-Associated Infertility: Multi-Omics Insights Into Pathogenesis and Precision Therapeutics,” Frontiers in Endocrinology 16 (2025): 1613334. - 35B. D. Wallace, A. B. Roberts, R. M. Pollet, et al., “Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity,” Chemistry & Biology 22, no. 9 (2015): 1238–1249, https://doi.org/10.1016/j.chembiol.2015.08.005. - 36M. Dabek, S. I. McCrae, V. J. Stevens, S. H. Duncan, and P. Louis, “Distribution of Beta-Glucosidase and Beta-Glucuronidase Activity and of Beta-Glucuronidase Gene Gus in Human Colonic Bacteria,” FEMS Microbiology Ecology 66, no. 3 (2008): 487–495, https://doi.org/10.1111/j.1574-6941.2008.00520.x. - 37T. Ogita, Y. Yamamoto, A. Mikami, S. Shigemori, T. Sato, and T. Shimosato, “Oral Administration of Flavonifractor plautii Strongly Suppresses Th2 Immune Responses in Mice,” Frontiers in Immunology 11 (2020): 379. - 38A. Mikami, T. Ogita, F. Namai, S. Shigemori, T. Sato, and T. Shimosato, “Oral Administration of Flavonifractor plautii Attenuates Inflammatory Responses in Obese Adipose Tissue,” Molecular Biology Reports 47 (2020): 6717–6725. - 39A. Mikami, T. Ogita, F. Namai, S. Shigemori, T. Sato, and T. Shimosato, “Oral Administration of Flavonifractor plautii, a Bacteria Increased With Green Tea Consumption, Promotes Recovery From Acute Colitis in Mice via Suppression of IL-17,” Frontiers in Nutrition 7 (2021): 610946. - 40H. Lu, X. Xu, D. Fu, et al., “Butyrate-Producing Eubacterium rectale Suppresses Lymphomagenesis by Alleviating the TNF-Induced TLR4/MyD88/NF-κB Axis,” Cell Host & Microbe 30 (2022): 1139–1150.e7. - 41P. S. Rawat, Y. Li, W. Zhang, X. Meng, and W. Liu, “Hungatella hathewayi, an Efficient Glycosaminoglycan-Degrading Firmicutes From Human Gut and Its Chondroitin ABC Exolyase With High Activity and Broad Substrate Specificity,” Applied and Environmental Microbiology 88 (2022): e0154622. - 42L. M. Costa, M. M. Mendes, A. C. Oliveira, et al., “Dietary Inflammatory Index and Its Relationship With Gut Microbiota in Individuals With Intestinal Constipation: A Cross-Sectional Study,” European Journal of Nutrition 61 (2022): 341–355. - 43K. Yamamoto, T. Honda, Y. Inukai, et al., “Identification of the Microbiome Associated With Prognosis in Patients With Chronic Liver Disease,” Microorganisms 12 (2024): 610. - 44M. Rosell-Díaz, E. Santos-González, A. Motger-Albertí, et al., “Gut Microbiota Links to Serum Ferritin and Cognition,” Gut Microbes 15 (2023): 2290318. - 45Q. Wang, S. X. Zhang, M. J. Chang, et al., “Characteristics of the Gut Microbiome and Its Relationship With Peripheral CD4+ T Cell Subpopulations and Cytokines in Rheumatoid Arthritis,” Frontiers in Microbiology 13 (2022): 799602. - 46M. Muñoz, E. Guerrero-Araya, C. Cortés-Tapia, A. Plaza-Garrido, T. D. Lawley, and D. Paredes-Sabja, “Comprehensive Genome Analyses of Sellimonas intestinalis, a Potential Biomarker of Homeostasis Gut Recovery,” Microbial Genomics 6 (2020): mgen000476. - 47O. Perdijk, R. Azzoni, and B. J. Marsland, “The Microbiome: An Integral Player in Immune Homeostasis and Inflammation in the respiratory Tract,” Physiological Reviews 104 (2024): 835–879. - 48D. Zheng, T. Liwinski, and E. Elinav, “Interaction Between Microbiota and Immunity in Health and Disease,” Cell Research 30 (2020): 492–506. - 49S. P. Monsanto, A. K. Edwards, J. Zhou, et al., “Surgical Removal of Endometriotic Lesions Alters Local and Systemic Proinflammatory Cytokines in Endometriosis Patients,” Fertility and Sterility 105 (2016): 968–977. - 50I. Seida, M. Al Shawaf, and N. Mahroum, “Fecal Microbiota Transplantation in Autoimmune Diseases—An Extensive Paper on a Pathogenetic Therapy,” Autoimmunity Reviews 23 (2024): 103541. - 51A. Boicean, V. Birlutiu, C. Ichim, P. Anderco, and S. Birsan, “Fecal Microbiota Transplantation in Inflammatory Bowel Disease,” Biomedicines 11 (2023): 1016. - 52X. Lu, Z. Shi, L. Jiang, and S. Zhang, “Maternal Gut Microbiota in the Health of Mothers and Offspring: From the Perspective of Immunology,” Frontiers in Immunology 15 (2024): 1362784. - 53K. Gorczyca, A. Obuchowska, Ż. Kimber-Trojnar, M. Wierzchowska-Opoka, and B. Leszczyńska-Gorzelak, “Changes in the Gut Microbiome and Pathologies in Pregnancy,” International Journal of Environmental Research and Public Health 19 (2022): 9961. Article Metrics Total unique accesses to an article’s full text in HTML or PDF/ePDF format.More metric information Scite metrics Explore this article's citation statements on scite.ai Share QR Code Generating QR code QR code copied to clipboard! Something went wrong while generating your QR code. Please try again in a moment. If the issue persists, refresh the page or contact support. Export citation Unable to load citation data. Please try again in a moment. How to cite Elkins, L. J., & Spiegelman, M. (2021). pyUserCalc: A revised Jupyter notebook calculator for uranium-series disequilibria in basalts. Earth and Space Science, 8, e2020EA001619. https://doi.org/10.1029/2020EA001619 Download Citation If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download. This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site. Citation manager file format Use the dropdown list to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex. You can then copy the formatted citation (as displayed) or download it as file, to your device. If the RefWorks format is chosen, the 'Download' button will be replaced with an option to directly export to RefWorks

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (50)

SciLite annotations

organisms 18
microbiota microbiota microbiota microbiota acidaminococcus lachnoclostridium paraprevotella odoribacter blautia sutterella flavonifractor eubacterium hungatella entiminae incertae sedis tuber sp. ag-2017b cecidomyiidi incertae sedis fournierella bacteria stick insect

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-07-28T06:09:08.634005+00:00
scilite
last seen: 2026-06-28T09:31:30.222730+00:00
License: CC0 · commercial use OK